Open AccessIntermediate-term outcomes after aortic valve replacement with a novel RESILIATM tissue bioprosthesis
Author(s) -
Krzysztof Bartuś,
Radosław Litwinowicz,
Agata Bilewska,
Maciej Stąpór,
Maciej Bochenek,
Jacek Różański,
Jerzy Sadowski,
Grzegorz Filip,
Bogusław Kapelak,
Mariusz Kuśmierczyk
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.07.33
Subject(s) - medicine , calcification , aortic valve replacement , aortic valve , cardiology , hemodynamics , observational study , surgery , stenosis
The durability of bioprosthetic heart valves is limited by structural valve deterioration (SVD) due to long-term calcification. A novel bioprosthetic tissue (RESILIA TM ) has been developed which, in preclinical studies, has shown reduced calcification. The purpose of this study was to evaluate the intermediate-term clinical outcomes and hemodynamic performance of this tissue.